Delivery Order SPE2DR25D3201-SPE2DR26FT4QA
- Not listed
- The Defense Logistics Agency awarded a $6,360.82 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections on November 26, 2025, with completion targeted for November 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will...
- The Defense Logistics Agency awarded a delivery order valued at $10,853.05 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections. This firm fixed-price, non-set-aside contract specifies performance through AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 2, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,047.44 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $26,577.38 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections on December 5, 2025, with completion targeted for December 8, 2025. This non-competitive delivery order represents a firm fixed price transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injectors, with a ceiling value of $22,436.20 and a firm fixed price structure. The contract is non-set-aside and competitively awarded, with an ultimate completion date of November 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1...
- The Defense Logistics Agency awarded a delivery order valued at $22,782.76 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 ml pen injections on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $33,236.84 and is scheduled for completion by August 7, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $4,251.71 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections on December 11, 2025, with completion scheduled for December 12, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections, with a contract ceiling value of $51,054.15. This firm fixed-price delivery order, which must be completed by November 18, 2025, represents a non-competitive, non-set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,906.45. The award, made on August 8, 2025, is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025. This non-competitive set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4QADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,903.16 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injections on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive IDC vehicle to supply a broad portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains. As a major healthcare solutions provider registered in the System for Award Management, the company demonstrates significant capability in fulfilling federal medical procurement requirements through open competition. This delivery order for Zepbound, a prescription diabetes and weight management medication, exemplifies AmerisourceBergen's role in supplying specialty pharmaceuticals to support the Defense Health Agency and other federal healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.9k | 12/9/25 |